Montelukast

Selectively blocks CysLT1 receptors, inhibiting leukotriene-mediated bronchoconstriction

• ·Multiple Myeloma
• ·Carcinoma, Non-Small-Cell Lung
• ·Parkinson Disease
• ·Refractory Multiple Myeloma
• ·Relapsed Multiple Myeloma

No curated interaction pairs are recorded for Montelukast. This is not a statement that none exist — check a full interaction reference before combining.

• Headache
• Abdominal pain
• Cough
• Rash

Half-life

2.7-5.5 hours

Protein binding

>99%

Metabolised by

CYP2C8, CYP3A4, CYP2C9

Not recorded for Montelukast. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.